Condition
Metabolic Complications
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06866119Not Yet Recruiting
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
NCT00682448Phase 4CompletedPrimary
Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
NCT00777647Not ApplicableCompleted
Effect of Carbonated Soft Drinks on the Body Weight
NCT01601899Phase 4Terminated
Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients
Showing all 4 trials